Maypro Selected as U.S. Distributor of AmealPeptide

November 2, 2012

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

PURCHASE, N.Y.Maypro Industries was selected by Tokyo-based CALPIS Co. Ltd. as the U.S. distributor of AmealPeptide®, a patented ingredient for healthy blood pressure support. The ingredient is derived from enzymatically hydrolyzed casein, and is a complete lactotripeptide, containing the VPP and IPP peptides. Maypro will highlight the ingredient at SupplySide West, booth #26010.

"We are very proud to add AmealPeptide to our select portfolio of proprietary branded ingredients," said Steve Yamada, Maypro's CEO. "It is an honor for us to represent one of Japan's leading beverage companies and to offer a product supported by such an extensive body of clinical research."

CALPIS has manufactured and sold fermented and cultured milk-based products since 1917, and is a well-known player in the functional foods/beverage markets in Japan and Europe. Shunsuke Fuji, senior officer, CALPIS, commented: "We are very glad to have this new partnership with Maypro. Maypro is an excellent company in cultivating proprietary branded ingredients. Through Maypro's distribution network, we hope more people will get a chance to take AmealPeptide so that we contribute to the improvement of everyones quality of life."

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like